Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Chloroquine × Thoracic × Clear all

Phase

Status

Sponsor Class

OTHER_GOV 1 OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 1

Interventions

Cisplatin 12 Carboplatin 11 Pemetrexed 10 Drug Therapy 9 Gemcitabine 8 Gefitinib 8 Docetaxel 7 camrelizumab 5 Radiotherapy 5 Paclitaxel 5 Nivolumab 5 Irinotecan 5 Erlotinib Hydrochloride 5 tislelizumab 4 apatinib 4 Simvastatin 4 Endostatins 4 Bevacizumab 4 pembrolizumab 3 endostar protein 3 Platinum Compounds 3 Etoposide 3 toripalimab 2 surufatinib 2 olaparib 2 durvalumab 2 atezolizumab 2 anlotinib 2 Topotecan 2 Thalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05647330 2022-12-12

Hydroxychloroquine Combined With Gemcitabine in the Treatment of Advanced Non-small Cell Lung Cancer

Henan Cancer Hospital

Phase 2 Unknown

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡